Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data
Statistics in Medicine · 2024-11-30 · 43 (27) · 5182-5192
DOI: 10.1002/sim.10230 ↗At a glance
Journal article in Statistics in Medicine, published online on 2024-10-07. Written by Jin Yang and 4 co-authors. Institution: Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Heal…. Major MEDLINE topics: COVID-19, Biomarkers, Chlamydia Infections, Computer Simulation. Cited 12 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Key Research and Development Program of China, Intramural NIH HHS.
Abstract (original language)
We consider the problem of combining multiple biomarkers to improve the diagnostic accuracy of detecting a disease when only group‐tested data on the disease status are available. There are several challenges in addressing this problem, including unavailable individual disease statuses, differential misclassification depending on group size and number of diseased individuals in the group, and extensive computation due to a large number of possible combinations of multiple biomarkers. To tackle these issues, we propose a pairwise model fitting approach to estimating the distribution of the optimal linear combination of biomarkers and its diagnostic accuracy under the assumption of a multivariate normal distribution. The approach is evaluated in simulation studies and applied to data on chlamydia detection and COVID‐19 diagnosis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
- Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
- Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID profiles: Jin Yang, Wei Zhang, Paul S Albert, Aiyi Liu, Zhen Chen
Funding
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Intramural NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NCI NIH HHS
- National Cancer Institute
Cite
APA
Yang, J., Zhang, W., Albert, P. S., Liu, A., & Chen, Z. (2024). Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data. Statistics in Medicine, 43(27), 5182-5192. https://doi.org/10.1002/sim.10230
Vancouver
Yang J, Zhang W, Albert PS, Liu A, Chen Z. Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data. Statistics in Medicine. 2024;43(27):5182-5192. doi:10.1002/sim.10230
BibTeX
@article{Yang2024,
author = {Yang, Jin and Zhang, Wei and Albert, Paul S and Liu, Aiyi and Chen, Zhen},
title = {Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data},
journal = {Statistics in Medicine},
year = {2024},
volume = {43},
number = {27},
pages = {5182--5192},
doi = {10.1002/sim.10230}
}
EUVIMED